Experience of using a combination of gemcitabine and carboplatin in the treatment of metastatic collecting duct (Bellini) carcinoma

Background. Collecting duct (Bellini) carcinoma is a prognostically unfavorable rare form of kidney tumors. As a therapeutic approach for metastatic disease, chemotherapy with a combination of gemcitabine and platinum-based drugs is recommended. Description of the clinical case. The article presents an analysis of a clinical case of treatment of a patient with metastatic carcinoma of Bellini ducts with a positive response to therapy. The dynamics and sequence of the use of imaging diagnostic methods are described, as well as the choice of treatment tactics for this patient. Conclusion. A clinical case indicates that the use of a combination of gemcitabine with platinum-based drugs is an effective option in the treatment of metastatic collecting duct (Bellini) carcinoma in a separate group of patients who are sensitive to treatment.

kidney cancer, carcinoma, Bellini ducts, chemotherapy, gemcitabine, carboplatin